Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Natalya N. Glonina"'
1
Akademický článek
Interim results of a multicenter retrospective-prospective observational post-marketing study of Extimia® BIOCAD (INN: empegfilgrastim) to evaluate safety and efficacy in patients with lymphoproliferative diseases receiving cytotoxic therapy
Autor: Ekaterina S. Nesterova, Tatyana Yu. Klitochenko, Natalya N. Glonina, Natalya V. Fadeeva, Tatyana A. Sannikova, Irina S. Lyalina, Tatyana V. Shelekhova, Dmitrij G. Sherstnev, Sergey V. Voloshin, Vladislav O. Sarzhevskii, Alina A. Hofman, Damir G. Ichshanov, Irina V. Poddubnaya
Publikováno v: Современная онкология, Vol 22, Iss 4, Pp 77-84 (2021)
Aim. To assess the efficacy and safety of using the drug Extimia BIOCAD (international nonproprietary name INN: empegfilgrastim) in order to reduce the frequency and duration of neutropenia, the frequency of febrile neutropenia (FN) and infections ma
Externí odkaz: https://doaj.org/article/f8ac47889d5d41f7a8c9e2650cc5399d
Zobrazit plný text záznamu
2
Akademický článek
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Autor: Irina V. Poddubnaya, Tatyana E. Bialik, Natalya N. Glonina, Olga B. Kalashnikova, Kamil D. Kaplanov, Valery A. Lapin, Nadezhda V. Medvedeva, Natalya B. Mikhailova, Tatyana N. Moiseeva, Evgeniy A. Nikitin, Tatyana I. Pospelova, Elena A. Stadnik
Publikováno v: Современная онкология, Vol 21, Iss 4, Pp 45-47 (2020)
Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia, with incidence rate of 4: 100 thousand per year, according to European data. CLL remains an incurable disease, with most patients over 60 years old. Immunochemotherapy sche
Externí odkaz: https://doaj.org/article/376175299edd4a2082a4d8ff2a8cf0a0
Zobrazit plný text záznamu
4
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Autor: T. I. Pospelova, Tatyana E. Bialik, EA Stadnik, Natalya N. Glonina, Nadezhda V. Medvedeva, Irina V. Poddubnaya, Evgeniy Aleksandrovich Nikitin, V A Lapin, K D Kaplanov, Olga B. Kalashnikova, Natalya B. Mikhailova, Moiseeva Tn
Publikováno v: Современная онкология, Vol 21, Iss 4, Pp 45-47 (2020)
Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia, with incidence rate of 4: 100 thousand per year, according to European data. CLL remains an incurable disease, with most patients over 60 years old. Immunochemotherapy sche
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059f43969dcfd4d98fb75d9105dd68c2
https://doi.org/10.26442/18151434.2019.4.190725
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje